It was a surprise to me. I never had a clue that I had any kind of condition going on. I was doing fine. Went in for an executive physical. And just as part of the normal screening process …

It was just sobering. Just looking at life and suddenly being faced with something that has the potential to impact your future in such a significant way.

We immediately kind of connected in terms of his triathlon experience and everything. And he just struck me as a very sharp, outstanding physician who covered all the bases and had excellent answers and seemed to be right up-to-date current on research and clinical studies, so I was very impressed.

You know, there's really a couple of goals as we go through treatment. But the main two are that we hope that the disease doesn't come back, that it's successful to eradicate any cells of activity. And the second is to try to protect the normal tissue so that patients can maintain a high quality of life in the long-run.

Radiation for prostate is typically done using linear accelerators. Courses of treatment usually last for several weeks at a time. In Dave's case, it was about 8-and-a-half weeks.

I started to feel the effects of the radiation therapy just in the last few weeks before the marathon. I mean, I could just watch my performance deteriorate. And it dropped off by 20% over a year period of time there. And I gained weight. I gained like 40 pounds.

It significantly affected training and affected my races. I mean, it became a focus of -- well, I'll just finish the race and keep going and keep doing the exercise and everything. But certainly, the fact that you continue to stay exercising and doing strength training is a huge help.

It means that patients are also more invested in their outcomes. And that's always a great thing. You have a sense that you'll have an easier time getting people through treatment when they're invested.
So I mean, that certainly was a big win and felt good. It achieved another milestone.

Yeah, we're pleased with how Dave has done. It's a testament to himself to really try to keep his body in great shape and be very fit. Because I think that does play a part in his ability to recover well from the treatment. Dave is a special guy.

Mental standpoint, this isn't a death sentence. This isn't the end of my current kind of view on things. This is just another speed bump in life, and we'll get over it.

Prostate cancer is the most common cancer among men. But men diagnosed with the disease have reason to be optimistic. Thanks to increased awareness, new diagnostic and management strategies, and improvements in therapies, more men are surviving prostate cancer today than ever before. Many others are safely followed without needing treatment.

The world-renowned prostate cancer team at the University of Chicago Medicine is highly skilled in the most up-to-date, technologically advanced methods for the diagnosis and treatment of prostate cancer. Our experts provide the full range of therapy options, including many that are not widely available. We believe in a personalized, comprehensive approach — working closely with you to help you choose the best treatment strategy for your condition and your unique situation.

Our multidisciplinary prostate cancer team — urologists, radiation oncologists, medical oncologists, pathologists and radiologists — collaborates with the goal of offering each patient innovative and high-quality care based on the latest research.

Focused on Your Quality of Life

Although treatments for prostate cancer are continuously advancing, they can have lasting side effects in some men. We strive to help you develop the right treatment course for your condition, one that offers a cure or effective management of the cancer while having the least possible impact on your health and your body.

Care for Older Men

The prostate cancer team works with the Specialized Oncology Care & Research in the Elderly (SOCARE) clinic at UChicago Medicine. SOCARE anticipates and addresses the specific needs of older men choosing treatment for prostate and other types of cancer.